SIP1 is a downstream effector of GADD45G in senescence induction and growth inhibition of liver tumor cells.
SIP1 is a downstream effector of GADD45G in senescence induction and growth inhibition of liver tumor cells.
复制标题
SIP1是GADD45G在肝肿瘤细胞衰老诱导和生长抑制中的下游效应子
DOI:
10.18632/oncotarget.5602
复制
发表时间:
2015-10-20
期刊:
影响因子:
--
通讯作者:
Liu Y
中科院分区:
文献类型:
--
作者:
Xu G;Zhang L;Ma A;Qian Y;Ding Q;Liu Y;Wang B;Yang Z;Liu Y
Cellular senescence evasion caused by the inactivation of tumor suppressive programs is implicated in tumor initiation and therapeutic resistance. Our previous study has shown that the downregulation of growth arrest and DNA damage 45G (GADD45G) contributes to senescence bypass in hepatocellular carcinoma (HCC). Here, we report that the Smad-interacting protein-1 (SIP1) is transcriptionally activated and functions critically in the GADD45G-induced tumor cell senescence. Knockdown of SIP1 significantly abrogates the suppressive effects of GADD45G on the growth of xenografted liver tumor in vivo. The essential role of SIP1 in GADD45G activities is further validated in the model of the proteasome inhibitor MG132-induced cell senescence. We further show that JNK but not p38 MAPK activation is involved in the GADD45G-mediated SIP1 upregulation, and that JNK inhibition counteracts the GADD45G-induced cellular senescence. More importantly, we show that GADD45G and SIP1 expression are coincidently downregulated in primary human HCC tissues. Together, our results establish that the dowregulation of GADD45G-SIP1 axis may contribute to cellular senescence evasion and HCC development.